Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas

Communications in Clinical Cytometry

Volumn 30, Issue 4, 1997, Pages 197-203

  Kunikane, Hiroshi ^a   Zalupski, Mark M ^b   Ramachandran, Cheppail ^a   Kukuruga, Mark A ^b   Lucas, David ^b   Ryan, James R ^b   Krishan, Awtar ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone sarcoma; Daunorubicin; Drug efflux; Flow cytometry; Multidrug resistance; P glycoprotein; Soft tissue sarcoma

Indexed keywords

DAUNORUBICIN; DIPYRIDAMOLE; GLYCOPROTEIN P; VERAPAMIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG ACCUMULATION; DRUG DETERMINATION; DRUG TRANSPORT; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES; ANTIGENS, CD45; BONE NEOPLASMS; CHILD; DAUNORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; LEIOMYOSARCOMA; LIPOSARCOMA; MALE; MIDDLE AGED; OSTEOSARCOMA; P-GLYCOPROTEIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0030848542     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19970815)30:4<197::AID-CYTO7>3.0.CO;2-H     Document Type: Article

References (36)

1. Beck WT, Mueller TJ, Tanzer LR: Altered surface membrane glycoprotein in vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res 39:2070-2076, 1979.
2. Blair SC, Zalupski MM, Baker LH: Ifosmamide and etposide in the treatment of advanced sarcomas. Am J Clin Oncol 17:480-484, 1994.
3. Chan HSL, Thorner PS, Haddad G, Ling V: Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8:689-704, 1990.
4. Chan HSL, Haddad G, Thorner PS, De Boer G, Lin YP, Ondrusek N, Yeger H, Ling V: P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 325:1608-1614, 1991.
5. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85-94, 1991.
6. Chen C, Chin JE, Ueda K, Clark PP, Pastan I, Gottesman MM, Robinson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidnig-resistant human cells. Cell 47:381-389, 1986.
7. Fojo A, Akiyama S, Gottesman MM, Pastan I: Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines. Cancer Res 45:3002-3007, 1985.
8. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I: Expression of multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265-269, 1987.
9. Gerlach JH, Bell DR, Karakousis C, Slocum HK, Kartner N, Rustum YM, Ling V, Baker RM: P-glycoprotein in human sarcoma: Evidence for multidrug resistance. J Clin Oncol 5:1452-1460, 1987.
10. Goldstein U, Galski H, Fojo AT, Willingham M, Lai S, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Giottesman MM, Pastan I: Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116-124, 1989.
11. Grogan TM, Spier CM, Salmon SE, Matzer M, Rybski J, Weinstein RS, Scheper RJ, Dalton WS: P-glycoprotein expression in human plasma cell myeloma: Correlation with prior chemotherapy. Blood 81:490-495, 1993.
12. Hamada H, Tsuruo T: Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies Proc Natl Acad Sci USA 83:7785-7789, 1986.
13. Ino T, Miqazaki H, Isogai M, Nomura T, Tsuzuki M, Tsuruo T, Ezaki K, Hiramo M: Expression of P-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: Results of molecular and functional assays, and correlation with treatment outcome Leukemia 8:1492-1497, 1994.
14. Juliano RL, Ling V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 455:152-162, 1976.
15. Krishan A, Sauerteig A, Gordon K, Swinkin C: Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells. Cancer Res 46:1768-1773, 1986.
16. Krishan A, Sridhar KS, Davila E, Vogel C, Sternheim W: Patterns of anthracycline retention modulation in human tumor cells Cytometry 8:306-314, 1987.
17. Krishan A, Sauerteig A, Stein JH: Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells. Cytometry 12:731-742, 1991.
18. Kunikane H, Krishan A, Ohta S, Nishio K, Kubota N, Takeda Y, Nomura K, Saijo N: Flow cytometric analysis of cellular adriamycin accumulation in small-cell lung cancer cell lines: Correlation of P-glycoprotein expression, cytotoxicity and intracellular distribution. Cellular Pharmocol 1:293-300, 1994.
19. Marie J, Faussat-Suberville A, Zhou D, Zittoun R: Daunorubicin uptake by leukemic cells: Correlations with treatment outcome and mdrl expression. Leukemia 7:825-831, 1993.
20. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47:207-214, 1981.
21. Naito M, Hamada H, Tsuruo T: ATP/Mg2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells. J Biol Chem 263:11887-11891, 1988.
22. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD: Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87:7160-7164, 1990.
23. Pirker R, Wallner J, Geissler K: MDRI gene expression and treatment outcome in acute mycloid leukemia. J Natl Cancer Inst 83:708-712. 1991.
24. Ramachandran C, Sauerteig A, Sridhar KS, Thurer RJ, Krishan A: MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients. Cancer Chemother Pharmacol 31:431-441, 1993
25. Ramachandran C, Yuan ZK, Huang XL, Krishan A: Doxorubicin resistance in human melanoma cells: MDR-I and glutathione s-transferasc II gene expression. Biochem Pharmacol 45:743-751. 1993.
26. Schlaifer D, Laurent G, Chinai S, Tsuruo T, Soues S, Muller C, Charcosset JY, Alard C, Brousset P, Mazerroles C: Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumor and stromal cells of human cancers. Br J Cancer 62:177-182, 1990.
27. Scotto KW, Biedler JL, Melera PW: Amplification and expression of genes associated with multidrug resistance in mammalian cells. Science 232:751-755, 1986.
28. Shalinsky DR, Andreeff M, Howell SB: Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro. Cancer Res 50:7537-7543, 1990.
29. Shen DW, Fojo A, Chin JE, Robinson I, Richen N, Pastan I, Gottesman MM: Human multidrug-resistant cell lines: Increased mdr1 expression can precede gene amplification. Science 232:643-645, 1986.
30. Stein U, Wunderlich V, Haensch W, Schmidt-Peter P: Expression of the mdr1 gene and soft tissue sarcomas of adult patients. Eur J Cancer 29A:1979-1981, 1993.
31. Streuli M, Morimoto C, Schrieber M, Schlossman SF, Saito H: Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens. J Immunol 141:3910-3914, 1988.
32. Toffoli G, Fruataci S, Tumiotto L, Talamini R, Gherlinzoni F, Picci P, Boiocchi M: Expression of MDR1 and GST-p in human soft tissue sarcomas: Relation to drug resistance and biological aggressiveness. Ann Oncol 3:63-69, 1992.
33. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y: Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972, 1981.
34. Van der Blick AM, Baas F, Van der Velde-Koerts T, Biedler JL, Meyers MB, Ozols RF, Hamilton TC, Joenje H, Borst P: Genes amplified and overexpression in human multidrug-rcsistant cell lines. Cancer Res 48:5927-5932, 1988.
35. Vergier B, Cany L, Bonnet F, Robert J, De Mascarel A, Coindre JM: Expression of MDR1/P glycoprotein in human sarcomas. Br J Cancer 68:1221-1226, 1993.
36. Verrelle P, Meissonnier F, Fonck Y, Feillel V, Dionet C, Kwiatkowski F, Plagne R, Chassagne J: Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst 83:III-116, 1991.